日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647]

对“泛亚洲版 ESMO 胆道癌患者诊断、治疗和随访临床实践指南”的更正:[ESMO Open 9 (2024) 103647]

Chen, L-T; Vogel, A; Hsu, C; Chen, M-H; Fang, W; Pangarsa, E A; Sharma, A; Ikeda, M; Park, J O; Tan, C K; Regala, E; Tai, D; Tanasanvimon, S; Charoentum, C; Chee, C E; Lui, A; Sow, J; Oh, D-Y; Ueno, M; Ramaswamy, A; Jeo, W S; Zhou, J; Curigliano, G; Yoshino, T; Bai, L-Y; Pentheroudakis, G; Chiang, N-J; Cervantes, A; Chen, J-S; Ducreux, M

Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysis

吉西他滨-白蛋白紫杉醇治疗失败后,转移性胰腺癌二线治疗方案为5-氟尿嘧啶联合纳米脂质体伊立替康对比FOLFOX/XELOX方案:倾向评分匹配分析

Trovato, G; Rossini, D; Guidolin, A; Su, Y-Y; Shan, Y-S; Chiang, N-J; Chou, W-C; Bai, L-Y; Bagalà, C; Bensi, M; Niger, M; Marchesi, S; Garattini, S K; Michelotti, A; Pretta, A; Scartozzi, M; Vivaldi, C; Bartalini, L; Procaccio, L; Bergamo, F; Antonuzzo, L; Chen, L-T; Salvatore, L; Tortora, G

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer

泛亚洲版ESMO胆道癌诊断、治疗和随访临床实践指南

Chen, L-T; Vogel, A; Hsu, C; Chen, M-H; Fang, W; Pangarsa, E A; Sharma, A; Ikeda, M; Park, J O; Tan, C K; Regala, E; Tai, D; Tanasanvimon, S; Charoentum, C; Chee, C E; Lui, A; Sow, J; Oh, D-Y; Ueno, M; Ramaswamy, A; Jeo, W S; Zhou, J; Curigliano, G; Yoshino, T; Bai, L-Y; Pentheroudakis, G; Chiang, N-J; Cervantes, A; Chen, J-S; Ducreux, M

The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan

UGT1A1多态性与脂质体伊立替康治疗毒性之间的关联

Su, Y-Y; Chiang, N-J; Chang, J S; Wang, Y-W; Shen, B-N; Li, Y-J; Hwang, D-Y; Shan, Y-S; Chen, L-T

Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients

纳米脂质体伊立替康(PEP02)治疗晚期实体瘤患者的I期研究

Chang, T C; Shiah, H S; Yang, C H; Yeh, K H; Cheng, A L; Shen, B N; Wang, Y W; Yeh, C G; Chiang, N J; Chang, J Y; Chen, L T

The Concise Guide to PHARMACOLOGY 2013/14: overview

《简明药理学指南 2013/14》:概述

Alexander, Stephen P H; Benson, Helen E; Faccenda, Elena; Pawson, Adam J; Sharman, Joanna L; McGrath, John C; Catterall, William A; Spedding, Michael; Peters, John A; Harmar, Anthony J; Abul-Hasn, N; Anderson, C M; Anderson, C M H; Araiksinen, M S; Arita, M; Arthofer, E; Barker, E L; Barratt, C; Barnes, N M; Bathgate, R; Beart, P M; Belelli, D; Bennett, A J; Birdsall, N J M; Boison, D; Bonner, T I; Brailsford, L; Bröer, S; Brown, P; Calo, G; Carter, W G; Catterall, W A; Chan, S L F; Chao, M V; Chiang, N; Christopoulos, A; Chun, J J; Cidlowski, J; Clapham, D E; Cockcroft, S; Connor, M A; Cox, H M; Cuthbert, A; Dautzenberg, F M; Davenport, A P; Dawson, P A; Dent, G; Dijksterhuis, J P; Dollery, C T; Dolphin, A C; Donowitz, M; Dubocovich, M L; Eiden, L; Eidne, K; Evans, B A; Fabbro, D; Fahlke, C; Farndale, R; Fitzgerald, G A; Fong, T M; Fowler, C J; Fry, J R; Funk, C D; Futerman, A H; Ganapathy, V; Gaisnier, B; Gershengorn, M A; Goldin, A; Goldman, I D; Gundlach, A L; Hagenbuch, B; Hales, T G; Hammond, J R; Hamon, M; Hancox, J C; Hauger, R L; Hay, D L; Hobbs, A J; Hollenberg, M D; Holliday, N D; Hoyer, D; Hynes, N A; Inui, K-I; Ishii, S; Jacobson, K A; Jarvis, G E; Jarvis, M F; Jensen, R; Jones, C E; Jones, R L; Kaibuchi, K; Kanai, Y; Kennedy, C; Kerr, I D; Khan, A A; Klienz, M J; Kukkonen, J P; Lapoint, J Y; Leurs, R; Lingueglia, E; Lippiat, J; Lolait, S J; Lummis, S C R; Lynch, J W; MacEwan, D; Maguire, J J; Marshall, I L; May, J M; McArdle, C A; McGrath, J C; Michel, M C; Millar, N S; Miller, L J; Mitolo, V; Monk, P N; Moore, P K; Moorhouse, A J; Mouillac, B; Murphy, P M; Neubig, R R; Neumaier, J; Niesler, B; Obaidat, A; Offermanns, S; Ohlstein, E; Panaro, M A; Parsons, S; Pwrtwee, R G; Petersen, J; Pin, J-P; Poyner, D R; Prigent, S; Prossnitz, E R; Pyne, N J; Pyne, S; Quigley, J G; Ramachandran, R; Richelson, E L; Roberts, R E; Roskoski, R; Ross, R A; Roth, M; Rudnick, G; Ryan, R M; Said, S I; Schild, L; Sanger, G J; Scholich, K; Schousboe, A; Schulte, G; Schulz, S; Serhan, C N; Sexton, P M; Sibley, D R; Siegel, J M; Singh, G; Sitsapesan, R; Smart, T G; Smith, D M; Soga, T; Stahl, A; Stewart, G; Stoddart, L A; Summers, R J; Thorens, B; Thwaites, D T; Toll, L; Traynor, J R; Usdin, T B; Vandenberg, R J; Villalon, C; Vore, M; Waldman, S A; Ward, D T; Willars, G B; Wonnacott, S J; Wright, E; Ye, R D; Yonezawa, A; Zimmermann, M

Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion.

Resolvin D1 和阿司匹林触发的 resolvin D1 调节组胺刺激的结膜杯状细胞分泌

Li D, Hodges R R, Jiao J, Carozza R B, Shatos M A, Chiang N, Serhan C N, Dartt D A

Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus

内源性促消退和抗炎脂质介质:一种新的药理学类别

Serhan, C N; Chiang, N